Lotus Pharm vs Horien Biochemical Technology: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and Horien Biochemical Technology (7814) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ Horien Biochemical Technology

0%+226%-30%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYHorien Biochemical TechnologyYoY
Oct 2026NT$2.13 billion-22.5%NT$4.7 million-7.4%
Sep 2026NT$2.77 billion+128.0%NT$8.5 million+4.0%
Aug 2026NT$2.11 billion+81.7%NT$7.1 million+12.7%
Jul 2026NT$2.49 billion+3.9%NT$13.7 million+36.5%
Jun 2026NT$3.4 billion+225.5%NT$14.8 million+209.3%
May 2026NT$2.32 billion+105.8%NT$4.5 million-29.8%
Apr 2026NT$3.09 billion+19.9%NT$5.4 million+3.3%
Mar 2026NT$4.35 billion+173.6%NT$16 million+112.1%
Feb 2026NT$2.24 billion+131.5%NT$2.9 million-13.6%
Jan 2026NT$2.05 billion-5.5%NT$4.8 million+27.2%
Dec 2025NT$2.44 billion+66.9%NT$12.3 million-25.3%
Nov 2025NT$1.06 billion-0.2%NT$10.1 million+16.1%
Oct 2025NT$2.75 billion+46.0%NT$5.1 million+1.4%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16